Showing results (731-740 of 771) with videos related to

Sort By:
Pageof 78
Bioorganic & Medicinal Chemistry Letters|March 6, 2012
Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptorHeng Xu, Haibo Zhang, Linbo Luan, et al.
Biomedical and Environmental Sciences : BES|April 2, 2023
Mechanism of Learning and Memory Impairment in Rats Exposed to Arsenic and/or Fluoride Based on Microbiome and MetabolomeXiao Li Zhang, Sheng Nan Yu, Ruo Di Qu, et al.
The International Journal of Biochemistry & Cell Biology|November 6, 2019
Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancerShanshan Wang, Jinrui Zhang, Taishu Wang, et al.
Chinese Journal of Cancer|January 13, 2017
Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulaeLi Ma, Guang-Yu Luo, Yu-Feng Ren, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonistsQinghua Meng, Baowei Zhao, Qiongfeng Xu, et al.
Carcinogenesis|June 11, 2014
MicroRNA-581 promotes hepatitis B virus surface antigen expression by targeting Dicer and EDEM1Yu-Qun Wang, Yong-Feng Ren, Yi-Jiang Song, et al.
Bioorganic & Medicinal Chemistry|September 24, 2013
Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitorsGuanghui Deng, Baowei Zhao, Yingli Ma, et al.
Elife|March 5, 2024
Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinomaTiesuo Zhao, Pengkun Wei, Congli Zhang, et al.
Cancer Medicine|April 30, 2026
Fruquintinib Plus TAS-102 With or Without SBRT as Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II TrialYi Wang, Jianfen Xu, Linchun Liang, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse AgonistsYonghui Wang, Wei Cai, Ting Tang, et al.
Pageof 78